CCR5 and HIV-1 infection: They showed that ZFN specifically disrupted ~50% of CCR5 alleles in a pool of primary human CD4+ T cells, and that stable and heritable protection occurred against HIV-1 infection in vitro and in vivo in a NOG model of HIV infection.